Skip to main content

Nizo, BaseClear Collaborate on Microbial Genomics

NEW YORK (GenomeWeb) – Nizo food research and BaseClear today announced an agreement aimed at microbial genomics research. 

The companies will combine BaseClear's genomic facilities and expertise with Nizo's knowledge about bacterial genetics and bioinformatics analysis to help customers choose microorganisms for industrial applications and conduct projects more cost effectively, they said. The solution will enable industry and academic researchers to get faster and more accurate data with integrated statistics and visualization, resulting in accelerated R&D. 

Financial and other terms of the deal were not disclosed. 

Nizo and BaseClear said that the partnership "offers new approaches for realizing an integrated metagenomics pipeline for efficient analyses of microbial communities." The solution they will offer includes experimental design advice, DNA extraction, a taxonomic annotation pipeline, an interactive browser for visualization, and first-line interpretation of results. 

Other solutions will be added later in the year to include genomic comparison, risk assessment, and functional gene content analysis, they said. 

Nizo is a Dutch contract research organization specializing in proteins, bacteria, and processing. BaseClear provides genomics solutions and also is based in the Netherlands.

The Scan

Response Too Slow, Cautious

A new report criticizes the global response to the threat of the COVID-19 pandemic, Nature News reports.

Pushed a Bit Later

Novavax has pushed back its timeline for filing for authorization for its SARS-CoV-2 vaccine, according to Bloomberg.

AMA Announces Anti-Racism Effort

The Associated Press reports that the American Medical Association has released a plan to address systemic racism in healthcare.

Nucleic Acids Research Papers on miRMaster 2.0, MutationTaster2021, LipidSuite

In Nucleic Acids Research this week: tool to examine small non-coding RNAs, approach to predict ramifications of DNA variants, and more.